Fig. 4
From: Oncogenic activation of EEF1A2 expression: a journey from a putative to an established oncogene
Expression of the EEF1A1/2 gene and its relationship with patient survival in different cancers. A, B TCGA datasets shows the expression level of EEF1A2 (A) and EEF1A1 (B) genes in ovarian cancer (OV), breast cancer (BRCA), prostate adenocarcinoma (PRAD), lung adenocarcinoma (LUAD), lung squamous cell carcinoma (LUSC), pancreatic adenocarcinoma (PAAD), liver hepatocellular carcinoma (LIHC), stomach adenocarcinoma (STAD), acute myeloid leukemia (LAML), and cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC). C Relationship between EEF1A2 gene (upper lane) and EEF1A1 gene (below lane) expression and overall cancer patient survival hazard ratio (HR). *P < 0.05